3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
28
Tumor-Agnostic
13
Thoracic
3
Head & Neck
1
Conditions
Nasopharyngeal Carcinoma
71
Nasopharyngeal Neoplasms
25
Head and Neck Neoplasms
25
Squamous Cell Carcinoma of Head and Neck
18
Neoplasm Metastasis
14
Carcinoma, Non-Small-Cell Lung
11
Recurrence
9
Salivary Gland Neoplasms
7
Ovarian Neoplasms
7
Stomach Neoplasms
6
Pancreatic Neoplasms
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Laryngeal Diseases
3
Epstein-Barr Virus Infections
3
Colonic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Osteosarcoma
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Interventions
pralsetinib
2
pembrolizumab
2
Cisplatin
2
trastuzumab deruxtecan
1
repotrectinib
1
liposomal doxorubicin
1
cabozantinib
1
bicalutamide
1
atezolizumab
1
Triptorelin Pamoate
1
Radiotherapy
1
Radiation
1
Quality of Life
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Gemcitabine
1
Drug Therapy
1
Doxorubicin
1
Carboplatin
1
CP protocol
1
Biological Therapy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Gemcitabine
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts